HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Behavioral effects of A71623, a highly selective CCK-A agonist tetrapeptide.

Abstract
We studied the behavioral effects of a novel cholecystokinin tetrapeptide (CCK-4) analogue, A71623, with full agonist activity and high affinity and selectivity for the CCK-A receptor subtype relative to the CCK-B receptor. In tests for anorectic activity, A71623 was found to suppress 60-min intakes of a liquid diet in both deprived and sated rats, and the effects were blocked by a selective CCK-A antagonist, A70104. Compared with CCK-8, A71623 was found to have improved potency and duration of action; the most potent route of administration was intraperitoneal. A71623 also suppressed the intake of a liquid diet and a 0.2 M sucrose solution in lean and obese Zucker rats. In daily injection studies, the anorectic activity of CCK-8 diminished rapidly, whereas the suppressant effects of A71623 on food intakes and body weight gains persisted throughout the 11-day treatment period. Finally, A71623 reduced the spontaneous locomotor activity of rats at doses above those required to suppress intakes. These studies are the first to describe the behavioral effects of a potent and highly selective CCK-A receptor agonist.
AuthorsK E Asin, L Bednarz, A L Nikkel, P A Gore Jr, W E Montana, M J Cullen, K Shiosaki, R Craig, A M Nadzan
JournalThe American journal of physiology (Am J Physiol) Vol. 263 Issue 1 Pt 2 Pg. R125-35 (Jul 1992) ISSN: 0002-9513 [Print] United States
PMID1636779 (Publication Type: Journal Article)
Chemical References
  • Peptides
  • Tetragastrin
  • A 71623
  • Cholecystokinin
  • Sincalide
Topics
  • Animals
  • Anorexia (chemically induced)
  • Behavior, Animal (drug effects)
  • Body Weight (drug effects)
  • Cholecystokinin (physiology)
  • Circadian Rhythm
  • Eating (drug effects)
  • Food Deprivation (physiology)
  • Male
  • Motor Activity (drug effects)
  • Peptides (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Sincalide (pharmacology)
  • Tetragastrin (administration & dosage, analogs & derivatives, pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: